As of 2025-07-11, the Intrinsic Value of Replimune Group Inc (REPL) is -16.04 USD. This REPL valuation is based on the model Peter Lynch Fair Value. With the current market price of 10.39 USD, the upside of Replimune Group Inc is -254.37%.
Based on its market price of 10.39 USD and our intrinsic valuation, Replimune Group Inc (REPL) is overvalued by 254.37%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -16.04 - -16.04 | -16.04 | -254.37% |
| P/E | (44.27) - (86.29) | (69.37) | -767.7% |
| DDM - Stable | (24.06) - (63.19) | (43.63) | -519.9% |
| DDM - Multi | (20.34) - (42.49) | (27.62) | -365.8% |
| Market Cap (mil) | 800.97 |
| Beta | 1.79 |
| Outstanding shares (mil) | 77.09 |
| Enterprise Value (mil) | 761.75 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.95% |
| Cost of Debt | 5.00% |
| WACC | 10.41% |